LabCompass

Anna Muraveva

Medicine · The Ohio State University

Mid career · publishing since 2014

Publications

20

Citations

139

Est. group size

~3

Recurring co-author estimate

Active years

12

Publishing since 2014

Research summary
AI-generated

This publication record appears to cover a mix of topics rather than a single focused research program, including bariatric surgery outcomes, breast cancer treatment markers, healthcare system efficiency, and EEG/vision studies. Because the listed works span such varied subjects and venues, it is unclear from the public bibliographic data alone whether these represent one continuous research direction or several distinct collaborations. Prospective students should look for more direct confirmation of current focus, as the topic relevance scores provided are all listed as zero, indicating low confidence in the topic classification.

Bariatric surgery outcomesBreast cancer treatment biomarkersHealthcare system efficiencyObesity and behavioral interventionsPhysiological/EEG measurement studies

Publication output has been low and fairly steady over the last decade, averaging under two papers per year with no clear growth or decline.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
2017: 2 publications172018: 1 publication182019: 2 publications192020: 2 publications202021: 4 publications4212022: 2 publications222023: 2 publications232024: 1 publication242025: 2 publications252026: 1 publication26
Recent publications
Publishes in
  • BMC Women s Health×2
  • Journal of the National Comprehensive Cancer Network×2
  • Cancer Epidemiology Biomarkers & Prevention×2
  • Annals of Surgery Open×1
  • Biochemistry (Moscow)×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile